Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Equine COVID-19 Antiserum (BSVEQAb) for COVID-19
NCT04834908Phase 2Terminated
- Sponsor
- Bharat Serums and Vaccines
- Start
- Jul 2021
- Primary completion
- May 2022
- Modality
- Antibody Conjugates, scFv Fragments, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of equine immunoglobulin anti SARS-CoV-2 in coronavirus disease 2019 (COVID-19), sponsored by Bharat Serums and Vaccines. Started Jul 2021; status: terminated.
02
Drugs
equine immunoglobulin anti SARS-CoV-2
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04834908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04834908.